Recombinant Mouse Anti-JEV E protein Antibody (E3.3) (CAT#: PABZ-153)

Recombinant Mouse Antibody (E3.3) is capable of binding to JEV E protein, expressed in Chinese Hamster Ovary cells (CHO). The identified neutralizing epitopes of the JEV domain III to its monoclonal antibody (mAb E3.3) by comparing NMR chemical shifts of the free(14kDa) and the antibody-bound (178 kDa) forms.


Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Published Data
  • Datasheet
  • MSDS
  • COA

Figure 1 Western blot analysis of the recombinant JEV E-Trx fusion proteins from the transformed cell lysate.

Figure 1 Western blot analysis of the recombinant JEV E-Trx fusion proteins from the transformed cell lysate.

The blot was probed with MAb E3.3 and was developed with an alkaline phosphatase-conjugated secondary antibody and NBT/BCIP substrates.

Lin, C. W., & Wu, S. C. (2003). A functional epitope determinant on domain III of the Japanese encephalitis virus envelope protein interacted with neutralizing-antibody combining sites. Journal of virology, 77(4), 2600-2606.

Figure 2 Relative immunoreactivities of the mutant domain III proteins to MAb E3.3 determined by ELISA.

Figure 2 Relative immunoreactivities of the mutant domain III proteins to MAb E3.3 determined by ELISA.

The wild-type, alanine substitution mutants (A), Ser-331 mutants (B), and Asp-332 mutants (C) were captured onto 96-well plates with rabbit anti-Trx antibodies, followed by incubation with a serial dilution of MAb E3.3. Bound MAb E3.3 was detected by using goat anti-mouse IgG-horseradish peroxidase conjugate and ABTS/H₂O₂ substrates. OD (405 nm), optical density at 405 nm.

Lin, C. W., & Wu, S. C. (2003). A functional epitope determinant on domain III of the Japanese encephalitis virus envelope protein interacted with neutralizing-antibody combining sites. Journal of virology, 77(4), 2600-2606.

Figure 3 Relative affinities of mutant and wild-type domain III fusion proteins for MAb E3.3 determined by ELISA

Figure 3 Relative affinities of mutant and wild-type domain III fusion proteins for MAb E3.3 determined by ELISA

Lin, C. W., & Wu, S. C. (2003). A functional epitope determinant on domain III of the Japanese encephalitis virus envelope protein interacted with neutralizing-antibody combining sites. Journal of virology, 77(4), 2600-2606.

Figure 4 JEV plaques recovered from inhibition of mAb E3.3-neutralization to JEV by the E6 phages (A), E14 phages (B) and E18 phages (C).

Figure 4 JEV plaques recovered from inhibition of mAb E3.3-neutralization to JEV by the E6 phages (A), E14 phages (B) and E18 phages (C).

The mAb E3.3 was incubated with 100 pfu JEV and a desired number of indicated phages, then recovered JEV plaques were obtained from the plaque determination on monolayers of BHK-21 cells.

Wu, S. C., & Lin, C. W. (2001). Neutralizing peptide ligands selected from phage-displayed libraries mimic the conformational epitope on domain III of the Japanese encephalitis virus envelope protein. Virus Research, 76(1), 59-69.

Figure 5 Neutralization titration curves of mAb E3.3 concentration (ascitic fluid) in three Japanese encephalitis viruses: CH2195 (closed circles), Beijing-1 (open circles) and Nakayama-N1H (boxes).

Figure 5 Neutralization titration curves of mAb E3.3 concentration (ascitic fluid) in three Japanese encephalitis viruses: CH2195 (closed circles), Beijing-1 (open circles) and Nakayama-N1H (boxes).

Wu, S. C., Lian, W. C., Hsu, L. C., & Liau, M. Y. (1997). Japanese encephalitis virus antigenic variants with characteristic differences in neutralization resistance and mouse virulence. Virus research, 51(2), 173-181.


Specifications

  • Immunogen
  • JEV Envelope protein
  • Host Species
  • Mouse
  • Derivation
  • Mouse
  • Type
  • IgG
  • Specificity
  • Tested positive against native JEV E protein
  • Species Reactivity
  • JEV
  • Clone
  • E3.3
  • Applications
  • WB 1:1000-1:5000
    ELISA Assay-Dependent
    Neut Assay-Dependent

Product Property

  • Purity
  • >95% by SDS-PAGE and HPLC analysis
  • Storage
  • Store the antibody (in aliquots) at -20°C. Avoid repeated freezing and thawing of samples.

Applications

  • Application Notes
  • The antibody E3.3 has been reported in applications of WB, ELISA, Neut. It's recommended that the optimal antibody concentration, dilution, incubition time etc. are best to be carefully titrated in specific assays.

Target

  • Alternative Names
  • E protein; Envelope protein

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Clone E3.3"

See other products for "E protein"

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for PABZ-153. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare